JPMorgan raised the firm’s price target on Omnicell (OMCL) to $44 from $37 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q3 report.
JPMorgan raised the firm’s price target on Omnicell (OMCL) to $44 from $37 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q3 report.